SNSE 8-K: Fda approval

Faeth Therapeutics

Filed with the SEC on Nov 9, 2026 · accession 0001193125-26-452643

SNSE filed a 8-K (current report) with the SEC on Nov 9, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Summary of the filing

Faeth Therapeutics announced positive preliminary Phase 2 topline results from the PIK-201 trial evaluating PIKTOR in combination with paclitaxel in patients with advanced endometrial cancer.

For details, click here →How to read a 8-K →

Key details

RegistrantFaeth Therapeutics, Inc.

General counsel and secretaryChristopher W. Gerry

✦ Ask GOAX AI about this filing — what it means for SNSE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for SNSE?

Click here

Frequently asked questions

What did SNSE file with the SEC on Nov 9, 2026?

SNSE filed a 8-K (Fda approval). Faeth Therapeutics announced positive preliminary Phase 2 topline results from the PIK-201 trial evaluating PIKTOR in combination with paclitaxel in patients with advanced endometrial cancer.

What does a fda approval mean for SNSE stock?

For a small biotech one drug can be most of the company’s value. Approval opens sales; a rejection (complete response letter) can delay it by years.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other SNSE SEC filings

Get alerts when SNSE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

SNSE overview SNSE analysis SNSE news Latest SEC filings